Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?


Akyuz F., Cavus B., Iliaz R., Soyer O., Ormeci A., Evirgen S., ...More

European journal of gastroenterology & hepatology, vol.31, pp.777-780, 2019 (SCI-Expanded) identifier identifier identifier